Table 4

Randomised prospective multicentre study on tPA in cases with fibrin formation after cataract surgery

(A) Presence of fibrin
Days after treatment tPA (n=44) Standard therapy (n=41) Statistical significance
Any intraocular fibrin:
Before therapy100%100%ns
159.1%95.1%p=0.001
259%90.3%p=0.001
1411.4%29.3%p=0.039
900%2.4%ns
Anterior chamber fibrin:
Before therapy84.1%85.4%ns
145.5%80.5%p=0.0009
243.2%78.0%p=0.001
142.3%9.8%ns
900%0%ns
IOL surface fibrin:
Before therapy97.7%92.7%ns
1ndndnd
247.7%80.5%p=0.000067
149.1%24.4%p=0.05
900%2.4%ns
(B) Rate of intraocular fibrin 1 and 14 days after treatment
Days after treatment tPA (n=44) Standard therapy (n=41)
1 14 90 1 14 90
None40.9%93.2%100%4.9%75.6%97.6%
Mild31.8%6.8%0%46.3%24.4%2.4%
Moderate25%0%0%39%0%0%
Severe2.3%0%0%9.8%0%0%
  • U test: day 1: p=0.00069; day 14: p=0.025; day 90: ns.

  • nd=not documented, ns=no significant difference.